tiprankstipranks
Icu Medical (DE:IC7)
FRANKFURT:IC7

ICU Medical (IC7) Income Statement

0 Followers

ICU Medical Income Statement

Last quarter (Q3 2023), ICU Medical's total revenue was $553.31M, a decrease of -7.45% from the same quarter last year. In Q3, ICU Medical's net income was $21.56M. See ICU Medical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 2.25B$ 2.28B$ 1.32B$ 1.27B$ 1.27B$ 1.40B
Cost of Revenue
$ 699.91M$ 1.58B$ -824.82M$ 809.51M$ 794.34M$ 830.01M
Gross Profit
$ 743.23M$ 697.76M$ 491.49M$ 461.50M$ 471.86M$ 570.03M
Operating Expense
$ 358.81M$ 740.66M$ -368.25M$ 325.93M$ 331.33M$ 372.87M
Operating Income
$ 61.97M$ -42.90M$ 123.25M$ 135.57M$ 140.53M$ 197.16M
Net Non Operating Interest Income Expense
$ -25.93M$ -66.38M$ -2.04M$ -1.75M$ -549.00K$ -709.00K
Other Income Expense
$ 556.55M$ -26.95M$ -2.51B$ -36.32M$ -25.28M$ -174.08M
Pretax Income
$ -63.06M$ 28.43M$ 123.19M$ 97.49M$ 114.71M$ 22.37M
Tax Provision
$ -35.02M$ -40.12M$ 20.05M$ 10.62M$ 13.67M$ -6.42M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -13.72M$ 68.56M$ 103.14M$ 86.87M$ 101.03M$ 28.79M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 1.06B$ 2.32B$ -1.19B$ 1.14B$ 1.13B$ 1.20B
Net Income From Continuing And Discontinued Operation
$ -28.04M$ -74.29M$ 103.14M$ 86.87M$ 101.03M$ 28.79M
Normalized Income
$ -45.54M$ 29.06M-$ 120.20M$ 130.26M$ 120.62M
Interest Expense
---$ 1.75M$ 549.00K$ 709.00K
EBIT
$ 63.04M$ 161.58M$ 122.33M$ 99.25M$ 115.26M$ 23.08M
EBITDA
$ 324.97M$ 454.13M$ 222.51M$ 184.88M$ 200.47M$ 97.82M
Currency in USD

ICU Medical Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis